IRIS Accounts Production v26.1.10.61 11872375 director 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118723752025-03-31118723752026-03-31118723752025-04-012026-03-31118723752024-03-31118723752024-04-012025-03-31118723752025-03-3111872375ns15:EnglandWales2025-04-012026-03-3111872375ns14:PoundSterling2025-04-012026-03-3111872375ns10:Director12025-04-012026-03-3111872375ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3111872375ns10:SmallEntities2025-04-012026-03-3111872375ns10:AuditExemptWithAccountantsReport2025-04-012026-03-3111872375ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3111872375ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3111872375ns10:FullAccounts2025-04-012026-03-3111872375ns10:OrdinaryShareClass12025-04-012026-03-3111872375ns5:CurrentFinancialInstruments2026-03-3111872375ns5:CurrentFinancialInstruments2025-03-3111872375ns5:ShareCapital2026-03-3111872375ns5:ShareCapital2025-03-3111872375ns5:RetainedEarningsAccumulatedLosses2026-03-3111872375ns5:RetainedEarningsAccumulatedLosses2025-03-3111872375ns10:RegisteredOffice2025-04-012026-03-3111872375ns5:ComputerEquipment2025-04-012026-03-3111872375ns5:ComputerEquipment2025-03-3111872375ns5:ComputerEquipment2026-03-3111872375ns5:ComputerEquipment2025-03-3111872375ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3111872375ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3111872375ns10:OrdinaryShareClass12026-03-31
REGISTERED NUMBER: 11872375 (England and Wales)














Treat-Mentor Ltd

Unaudited Financial Statements

for the Year Ended 31 March 2026






Treat-Mentor Ltd (Registered number: 11872375)

Contents of the Financial Statements
for the Year Ended 31 March 2026










Page

Chartered accountants' report 1

Statement of financial position 2

Notes to the financial statements 3


Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Treat-Mentor Ltd


The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of financial position. Readers are cautioned that the Income statement and certain other primary statements and the Director's report are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Treat-Mentor Ltd for the year ended 31 March 2026 which comprise the Income statement, Statement of financial position, Statement of changes in equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Treat-Mentor Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Treat-Mentor Ltd and state those matters that we have agreed to state to the director of Treat-Mentor Ltd in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Treat-Mentor Ltd and its director for our work or for this report.

It is your duty to ensure that Treat-Mentor Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Treat-Mentor Ltd. You consider that Treat-Mentor Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Treat-Mentor Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Moore Thompson
22 St George's Street
Stamford
Lincolnshire
PE9 2BU


12 August 2026

Treat-Mentor Ltd (Registered number: 11872375)

Statement of Financial Position
31 March 2026

2026 2025
Notes £    £    £    £   
Fixed assets
Tangible assets 5 1,100 837

Current assets
Stocks 6 976 1,474
Debtors 7 - 5,758
Cash at bank 22,721 22,864
23,697 30,096
Creditors
Amounts falling due within one year 8 17,647 19,003
Net current assets 6,050 11,093
Total assets less current liabilities 7,150 11,930

Capital and reserves
Called up share capital 9 100 100
Retained earnings 7,050 11,830
Shareholders' funds 7,150 11,930

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12 August 2026 and were signed by:





P Lambart - Director


Treat-Mentor Ltd (Registered number: 11872375)

Notes to the Financial Statements
for the Year Ended 31 March 2026


1. Statutory information

Treat-Mentor Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11872375

Registered office: 22 St Georges Street
Stamford
Lincolnshire
PE9 2BU

The presentation currency of the financial statements is the Pound Sterling (£).


2. Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. Accounting policies

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer & office equipment - 25% on reducing balance

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible asset includes directly attributable incremental costs incurred in their acquisition and installation.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Treat-Mentor Ltd (Registered number: 11872375)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026


3. Accounting policies - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Going concern
The financial statements have been prepared on a going concern basis which assumes that the company will continue in operational existence for the foreseeable future. The validity of this assumption depends upon an improvement in the company's trading position and continued financial support from its directors, shareholders and related companies and partnerships. The financial statements do not include any adjustments that would arise if such support is not continuing.

4. Employees and directors

The average number of employees during the year was 1 (2025 - 1 ) .

Treat-Mentor Ltd (Registered number: 11872375)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026


5. Tangible fixed assets
Computer
& office
equipment
£   
Cost
At 1 April 2025 1,511
Additions 522
At 31 March 2026 2,033
Depreciation
At 1 April 2025 674
Charge for year 259
At 31 March 2026 933
Net book value
At 31 March 2026 1,100
At 31 March 2025 837

6. Stocks
2026 2025
£    £   
Stocks 976 1,474

7. Debtors: amounts falling due within one year
2026 2025
£    £   
Trade debtors - 5,600
Prepayments - 158
- 5,758

8. Creditors: amounts falling due within one year
2026 2025
£    £   
Tax - 196
Other creditors 14,472 14,474
Directors' loan accounts 1,675 2,666
Accrued expenses 1,500 1,667
17,647 19,003

9. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £    £   
100 Ordinary shares £1 100 100